Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Chimerigen
SCF (human):Fc (mouse) (rec.)
Product Details | |
---|---|
Synonyms | Stem Cell Factor; c-Kit Ligand; Kit Ligand; Mast Cell Grow Factor; MGF |
Product Type | Protein |
Properties | |
Source/Host | CHO cells |
Sequence |
The extracellular domain of human SCF (aa 26-187) is fused to the N-terminus of the Fc region of mouse IgG2a. |
Crossreactivity | Human |
MW | ~50-60kDa |
Purity | ≥98% (SDS-PAGE) |
Endotoxin Content | <1EU/mg protein (LAL test; Lonza). |
Reconstitution |
Reconstitute in 50µl sterile water. Add 1X PBS to the desired protein concentration. |
Formulation | Lyophilized from 0.2μm-filtered solution in PBS. |
Protein Negative Control | |
Other Product Data |
NCBI reference NP_003985.2: SCF (human) |
Declaration | Manufactured by Chimerigen. |
Shipping and Handling | |
Shipping | BLUE ICE |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice |
Avoid freeze/thaw cycles. Centrifuge lyophilized vial before opening and reconstitution. |
Use/Stability |
Stable for at least 1 year after receipt when stored at -20°C. Working aliquots are stable for up to 3 months when stored at -20°C. |
Documents | |
MSDS | Inquire |
Product Specification Sheet | |
Datasheet | Download PDF |
Stem cell factor (SCF), also known as cKit ligand (KL), mast cell growth factor (MGF), and steel factor (SLF), is a widely expressed 28-40 kDa type I transmembrane glycoprotein. It promotes the survival, differentiation, and mobilization of multiple cell types including myeloid, erythroid, megakaryocytic, lymphoid, germ cell, and melanocyte progenitors. SCF is a primary growth and activation factor for mast cells and eosinophils. Noncovalent dimers of transmembrane or soluble SCF interact with the receptor tyrosine kinase SCF R/cKit to trigger receptor dimerization and signaling. SCF assists in the recovery of cardiac function following myocardial infarction by increasing the number of cardiomyocytes and vascular channels.